| abstract |
Treat or prevent diseases, disorders, and conditions associated with or related to CD73, including compounds and compositions that inhibit CD73 (also known as ect-5'-nucleotidase), and cancer-related and immune-related disorders. Provide its use for. CD73 inhibitor compounds include compounds having the structure of formula I and pharmaceutically acceptable esters or salts thereof. |